BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 18695389)

  • 21. Aliskiren: an oral direct renin inhibitor for the treatment of hypertension.
    Sanoski CA
    Pharmacotherapy; 2009 Feb; 29(2):193-212. PubMed ID: 19170589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aliskiren for hypertension in adults.
    Drug Ther Bull; 2008 Oct; 46(10):73-6. PubMed ID: 18832257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aliskiren, the future of renin-angiotensin system blockade?
    Uresin Y; Mehtar Bozkurt M; Sabirli S; Ozunal ZG
    Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):835-49. PubMed ID: 17867914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Is there a need for direct renin inhibitors?].
    Grossman E
    Harefuah; 2008 Mar; 147(3):216-7, 278. PubMed ID: 18488862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New insights into the renoprotective actions of the renin inhibitor aliskiren in experimental renal disease.
    Feldman DL
    Hypertens Res; 2010 Apr; 33(4):279-87. PubMed ID: 20203685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What is the role of direct renin inhibitors in the treatment of the hypertensive diabetic patient?
    de la Sierra A; Salazar J
    Adv Ther; 2011 Sep; 28(9):716-27. PubMed ID: 21809181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aliskiren versus ramipril in hypertension.
    Verdecchia P; Angeli F; Mazzotta G; Martire P; Garofoli M; Gentile G; Reboldi G
    Ther Adv Cardiovasc Dis; 2010 Jun; 4(3):193-200. PubMed ID: 20418269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unmet needs in managing hypertension: potential role of direct renin inhibition.
    Ruddy MC
    Postgrad Med; 2010 May; 122(3):203-12. PubMed ID: 20463431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Renin inhibitors--new direction in the treatment of arterial hypertension].
    Vasiuk IuA; Sadulaeva IA; Iushchuk EN; Trofimenko OS; Chirkov MV; Fedoseeva VS; Kulikov KG
    Ter Arkh; 2010; 82(9):53-9. PubMed ID: 21086622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Advantages and limitations of renin inhibition with aliskiren].
    Azizi M; Frank M; Steichen O; Blanchard A
    Ann Pharm Fr; 2011 May; 69(3):142-50. PubMed ID: 21570538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Managing cardiovascular and renal risk: the potential of direct renin inhibition.
    Sever PS; Gradman AH; Azizi M
    J Renin Angiotensin Aldosterone Syst; 2009 Jun; 10(2):65-76. PubMed ID: 19502253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aliskiren as a novel therapeutic agent for hypertension and cardio-renal diseases.
    Rashikh A; Ahmad SJ; Pillai KK; Najmi AK
    J Pharm Pharmacol; 2012 Apr; 64(4):470-81. PubMed ID: 22420653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOSPHERE) study.
    Krum H; Massie B; Abraham WT; Dickstein K; Kober L; McMurray JJ; Desai A; Gimpelewicz C; Kandra A; Reimund B; Rattunde H; Armbrecht J;
    Eur J Heart Fail; 2011 Jan; 13(1):107-14. PubMed ID: 21169387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aliskiren: renin inhibitor for hypertension management.
    Cheng JW
    Clin Ther; 2008 Jan; 30(1):31-47. PubMed ID: 18343241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renin-angiotensin-aldosterone system blockade in high-risk hypertensive patients: current approaches and future trends.
    Gullapalli N; Bloch MJ; Basile J
    Ther Adv Cardiovasc Dis; 2010 Dec; 4(6):359-73. PubMed ID: 20965951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The biochemical pharmacology of renin inhibitors: implications for translational medicine in hypertension, diabetic nephropathy and heart failure: expectations and reality.
    Abassi Z; Winaver J; Feuerstein GZ
    Biochem Pharmacol; 2009 Oct; 78(8):933-40. PubMed ID: 19477166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aliskiren: beyond blood pressure reduction.
    Riccioni G; Vitulano N; Zanasi A; Bellocci F; d'Orazio N
    Expert Opin Investig Drugs; 2010 Oct; 19(10):1265-74. PubMed ID: 20812878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is there a future for direct renin inhibitors?
    Chaudhary K; Nistala R; Whaley-Connell A
    Expert Opin Investig Drugs; 2010 May; 19(5):653-61. PubMed ID: 20380486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Renin inhibition and the kidney].
    Ecder T
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():28-31. PubMed ID: 20019474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aliskiren: a novel renin inhibitor for hypertension.
    Tayal V; Kalra BS
    Indian Heart J; 2008; 60(1):69-72. PubMed ID: 19212031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.